{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:38:54Z","timestamp":1761748734459,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.acvd.2021.02.002","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T20:39:34Z","timestamp":1615322374000},"page":"173-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Atrial fibrillation and vascular disease: Coronary artery disease and\/or peripheral artery disease?"],"prefix":"10.1016","volume":"114","author":[{"given":"Hani","family":"Essa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2021.02.002_bib0105","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","article-title":"Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.acvd.2021.02.002_bib0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/a-1336-0576","article-title":"Embolic stroke of undetermined source: The need for an integrated and holistic approach to care","volume":"121","author":"Guo","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2021.02.002_bib0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2021.02.002_bib0120","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review","volume":"118","author":"Borre","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2021.02.002_bib0125","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in cooollaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.02.002_bib0130","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1055\/s-0039-1683933","article-title":"Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially \u201cLow-Risk\u201d Patients","volume":"119","author":"Chao","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2021.02.002_bib0135","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1080\/14656566.2020.1774556","article-title":"Current and emerging drug treatment strategies for peripheral arterial disease","volume":"21","author":"Essa","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.acvd.2021.02.002_bib0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2021.02.002_bib0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.thromres.2012.05.016","article-title":"Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation","volume":"130","author":"Aguilar","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2021.02.002_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2017.12.076","article-title":"Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation","volume":"255","author":"Pastori","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2021.02.002_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2008.06.029","article-title":"Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis","volume":"156","author":"Goto","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2021.02.002_bib0160","doi-asserted-by":"crossref","first-page":"826.e13","DOI":"10.1016\/j.amjmed.2011.11.024","article-title":"Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study","volume":"125","author":"Olesen","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.acvd.2021.02.002_bib0165","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1055\/s-0038-1651482","article-title":"Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study","volume":"118","author":"Yoon","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2021.02.002_bib0170","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-0038-1636534","article-title":"Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors","volume":"118","author":"Chao","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2021.02.002_bib0175","article-title":"Age-dependent anticoagulant therapy for atrial fibrillation patients with intermediate risk of ischemic stroke: A nationwide population-based study","author":"Choi","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2021.02.002_bib0180","article-title":"The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation","author":"Potpara","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2021.02.002_bib0185","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.02.002_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2020.03.019","article-title":"Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial","volume":"133","author":"Guo","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.acvd.2021.02.002_bib0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejim.2020.09.024","article-title":"Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort","volume":"82","author":"Guo","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.acvd.2021.02.002_bib0200","doi-asserted-by":"crossref","first-page":"e014932","DOI":"10.1161\/JAHA.119.014932","article-title":"Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial","volume":"9","author":"Proietti","year":"2020","journal-title":"J Am Heart Assoc"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213621000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213621000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:47:05Z","timestamp":1761745625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213621000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1875213621000486"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2021.02.002","relation":{},"ISSN":["1875-2136"],"issn-type":[{"type":"print","value":"1875-2136"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation and vascular disease: Coronary artery disease and\/or peripheral artery disease?","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2021.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}